BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 9309800)

  • 1. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
    Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
    Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach.
    Ogino K; Hatanaka K; Kawamura M; Ohno T; Harada Y
    Pharmacology; 2000 Nov; 61(4):244-50. PubMed ID: 11093076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study.
    Villegas I; Martín MJ; La Casa C; Motilva V; De La Lastra CA
    Free Radic Res; 2002 Jul; 36(7):769-77. PubMed ID: 12180128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of meloxicam, indomethacin or NS-398 on eicosanoid synthesis by fresh human gastric mucosa.
    Tavares IA
    Aliment Pharmacol Ther; 2000 Jun; 14(6):795-9. PubMed ID: 10848664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins.
    Konturek PC; Brzozowski T; Konturek SJ; Taut A; Kwiecien S; Pajdo R; Sliwowski Z; Hahn EG
    Digestion; 1998; 59(4):284-97. PubMed ID: 9693198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.
    Engelhardt G; Bögel R; Schnitzler C; Utzmann R
    Biochem Pharmacol; 1996 Jan; 51(1):29-38. PubMed ID: 8534265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4'-isomer.
    Pairet M; van Ryn J; Schierok H; Mauz A; Trummlitz G; Engelhardt G
    Inflamm Res; 1998 Jun; 47(6):270-6. PubMed ID: 9683035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
    Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation.
    Gilroy DW; Tomlinson A; Willoughby DA
    Eur J Pharmacol; 1998 Aug; 355(2-3):211-7. PubMed ID: 9760036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress-induced gastric lesions in rats.
    Nakatsugi S; Terada N; Yoshimura T; Horie Y; Furukawa M
    Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):395-402. PubMed ID: 9014217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing profiles of prostaglandin formation inhibition between selective prostaglandin H synthase-2 inhibitors and conventional NSAIDs in inflammatory and non-inflammatory sites of the rat.
    Harada Y; Kawamura M; Hatanaka K; Saito M; Ogino M; Ohno T; Ogino K; Yang Q
    Prostaglandins Other Lipid Mediat; 1998 Apr; 55(5-6):345-58. PubMed ID: 9653772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central antinociceptive effects of meloxicam on rat spinal cord in vitro.
    Lopez-Garcia JA; Laird JM
    Neuroreport; 1998 Mar; 9(4):647-51. PubMed ID: 9559932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation.
    Pinheiro RM; Calixto JB
    Inflamm Res; 2002 Dec; 51(12):603-10. PubMed ID: 12558194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
    Panara MR; Renda G; Sciulli MG; Santini G; Di Giamberardino M; Rotondo MT; Tacconelli S; Seta F; Patrono C; Patrignani P
    J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Drozdowicz D; Stachura J; Pajdo R; Hahn EG
    Eur J Pharmacol; 1999 Nov; 385(1):47-61. PubMed ID: 10594344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
    Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series.
    Song Y; Connor DT; Doubleday R; Sorenson RJ; Sercel AD; Unangst PC; Roth BD; Gilbertsen RB; Chan K; Schrier DJ; Guglietta A; Bornemeier DA; Dyer RD
    J Med Chem; 1999 Apr; 42(7):1151-60. PubMed ID: 10197959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes.
    Tsubouchi Y; Sano H; Yamada R; Hashiramoto A; Kohno M; Kusaka Y; Kondo M
    Eur J Pharmacol; 2000 May; 395(3):255-63. PubMed ID: 10812057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.